FDA Import Refusal 1FX-8489145-6/10002/1 — CADILA PHARMACEUTICALS LTD
The FDA refused shipment 1FX-8489145-6/10002/1 from CADILA PHARMACEUTICALS LTD (India) on Aug 14, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 14, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75